Metacam Boehringer Ingelheim Oral suspension for CATS 32ml
Metacam® Oral Suspension for Cats is the most popular medicine used by vets to treat arthritis in cats. It is a non-steroidal anti-inflammatory drug (NSAID) recommended by vets for the treatment of arthritis in both dogs and cats.1
It works by relieving pain and inflammation associated with arthritis. Therefore, it plays a vital role in improving quality and enjoyment of life of cats with arthritis.
Most cats love the honey flavoured Metacam® Oral Suspension which can be added to food or given directly to your cat, making it very easy to give.
Metacam® is also available as an injection, and can be used around the time of surgery to help manage the associated pain. Sometimes your vet will also dispense a bottle of the Metacam Oral Suspension after surgery to help keep your cat as comfortable as possible during the recovery period.
Metacam Oral Suspension for Cats is a non-steroidal anti-inflammatory drug (NSAID) which is often used to treat arthritis in cats. Metacam is for alleviation of inflammation and pain in chronic musculo-skeletal disorders.
Metacam for Cats initial treatment is a single oral dose of 0.1 mg meloxicam/kg bodyweight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.05 mg meloxicam/kg bodyweight.
Particular care should be taken with regard to the accuracy of dosing. The recommended dose should not be exceeded.
Shake the bottle well before use. To be administered orally either mixed with food or directly into the mouth. The suspension can be given using the drop dispenser of the bottle for cats of any bodyweight. Alternatively and for cats with a bodyweight of at least 2 kg, the Metacam measuring syringe (provided in the package) can be used.
Metacam Cat Dosing procedure using the drop dispenser of the bottle
Initial dose : 6 drops/kg bodyweight.
Maintenance dose : 3 drops/kg bodyweight.
Metacam Cat Dosing procedure using the measuring syringe
The syringe fits onto the drop dispenser of the bottle and has a kg-bodyweight scale which corresponds to the maintenance dose. Thus for initiation of the therapy on the first day, twice the maintenance volume will be required. A clinical response is usually seen within 7 days. Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent. Avoid the introduction of contamination during use.
